Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 635

Results For "Act"

7963 News Found

Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug
Drug Approval | April 20, 2022

Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug

Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA


SoftBank Robotics takes a five per cent stake in Avalon SteriTech
Digitisation | April 20, 2022

SoftBank Robotics takes a five per cent stake in Avalon SteriTech

Strive to empower public health with disinfection robotics solutions in post-pandemic era


Celogics license in NEXEL's Cardiosight-S for global distribution
Biotech | April 20, 2022

Celogics license in NEXEL's Cardiosight-S for global distribution

The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development


SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
Biotech | April 20, 2022

SNIPR BIOME initiates first-in-human clinical trial with SNIPR001

The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut


MicroGEM granted EUA for Covid-19 PCR Saliva test
Biotech | April 20, 2022

MicroGEM granted EUA for Covid-19 PCR Saliva test

The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes


Asahi Kasei Medical to acquire US based CDMO Bionova Scientific
Biotech | April 19, 2022

Asahi Kasei Medical to acquire US based CDMO Bionova Scientific

Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture


Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon
Biotech | April 19, 2022

Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon

By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)


Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India
News | April 19, 2022

Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India

Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer


WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19
News | April 19, 2022

WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19

The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19


Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)
Medical Device | April 19, 2022

Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)

Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey